Understand · Treat · Recover

Follow-Up, Remission and Survivorship

Follow-up supports recovery, detects concerning changes and helps people live with uncertainty.

This guide is educational and does not replace individual medical assessment. Do not start, stop or change treatment without the treating team. Cancer Aware supports patients and families worldwide. Drug approvals, availability, affordability and care pathways vary by country.

Chapter 19 of 20

What remission means

A complete response means no detectable disease on the assessments used; microscopic disease can still remain. Partial response means measurable improvement without disappearance of all disease. “No evidence of disease” is encouraging but is not a guarantee that cancer can never return. Survivorship support begins at diagnosis, not only after treatment ends.

Agree on the monitoring plan

Follow-up commonly includes symptom review and examination, with CA-125 when it is informative and agreed, and imaging when clinically indicated. Frequency is individual and often greater in the first years. Routine repeated imaging or blood tests are not automatically helpful for everyone. CA-125 testing has trade-offs: detecting a rise earlier does not necessarily mean that earlier chemotherapy improves survival.

Care beyond recurrence detection

  • Review neuropathy, fatigue, menopause, bone health and emotional distress.
  • Maintain other recommended health screening and vaccinations with the clinical team.
  • Keep a treatment summary including surgery, drugs, major reactions and genetic results.
  • Ask about returning to work, exercise and intimacy at a realistic pace.

Fear of recurrence

Anxiety before appointments is common. A clear symptom plan, planned access to the team and counselling can reduce the burden. Report persistent new abdominal symptoms, bowel changes, unexplained weight changes or breathlessness between visits. Do not wait for a scheduled marker test if clinically unwell.

Key takeaway

A good follow-up plan addresses recovery and wellbeing as well as possible recurrence.

Common questions

Does remission mean cure?

Not necessarily. It describes the current response, while cure can only be judged over time.

Should everyone have regular CT scans?

No. The schedule depends on clinical need and the follow-up strategy.

Must every CA-125 rise trigger treatment?

No. Interpret the trend with symptoms, scans and preferences.

Can symptoms persist after treatment?

Yes. Persistent symptoms deserve assessment and support, even with no evidence of cancer.

Who coordinates care after treatment?

Ask which oncology and primary-care clinicians are responsible for each part of follow-up.

Sources and further reading